Comparison of hemostatic factors and serum malondialdehyde as predictive factors for cardiovascular disease in hemodialysis patients
- 30 September 1999
- journal article
- Published by Elsevier BV in American Journal of Kidney Diseases
- Vol. 34 (3), 438-444
- https://doi.org/10.1016/s0272-6386(99)70070-3
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Lipid peroxidation products and antioxidants in human disease.Environmental Health Perspectives, 1998
- Factor VII coagulant activity (VIIc) and hypercoagulability in chronic renal disease and dialysis: relationship with dyslipidaemia, inflammation, and factor VII genotypeNephrology Dialysis Transplantation, 1998
- Detection of oxidants in uremic plasma by electron spin resonance spectroscopyKidney International, 1995
- Lipoperoxidation in plasma and red blood cells of patients undergoing haemodialysis: Vitamins A, E, and iron statusFree Radical Biology & Medicine, 1994
- Enhanced LDL oxidation in uremic patients: An additional mechanism for accelerated atherosclerosis?Kidney International, 1994
- Coenzyme Q10 levels, plasma lipids and peroxidation extent in renal failure and in hemodialytic patientsMolecular Aspects of Medicine, 1994
- Serum Coenzyme Q10 in Uremic Patients on Chronic HemodialysisNephron, 1994
- Plasma Lipids Are Not Oxidized during HemodialysisNephron, 1994
- Erythrocyte defense mechanisms against free oxygen radicals in haemodialysed uraemic childrenPediatric Nephrology, 1991
- Vitamin Levels in Chronic Renal Failure and Need for SupplementationBlood Purification, 1985